HPV Screening with Self Collection Endorsed by Two Organizations
At the end of 2025, the American Cancer Society released its new cervical cancer screening guidelines. In January 2026, the Health Resources and Services Administration endorsed a new set of guidelines as well. Both suggest HPV screening with self collected samples is an acceptable option.
Is One Shot of the HPV Vaccine Enough?
Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
Australia is Closer to Ending Cervical Cancer
Australia has been a leader in HPV-prevention and cervical cancer screening for decades. Because of this, it is now close to eliminating cervical cancer entirely. However, recent drops in vaccination and screening rates threaten this progress.
ACS Releases New Cervical Cancer Screening Guidelines
The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.
FDA Approves At-Home Collection Device for Cervical Cancer Screening
The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.
One and Done? New Study Suggests that One Dose of HPV Vaccine May Be Enough
The results of large-scale study of HPV suggest that one shot of the vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
Human Papillomavirus (HPV)—Understanding this Common Infection
There are over 100 different types of human papillomavirus, or HPV. Some types of HPV can cause genital warts and other types can cause cancer, including cancer of the cervix, vulva, vagina, penis or anus, as well as cancer in the back of the throat.
Cervical Cancer Screening Rates Haven’t Rebounded After the Pandemic
The pandemic interrupted our regularly scheduled doctor’s visits and pushed off preventative care like Pap tests.
New Study Shows a Dramatic Drop in Cervical Pre-Cancers
A new study has found a dramatic drop in the rates of cervical pre-cancers among young adult women. This is great news and further proof that the HPV vaccine is working.
The HPV Vaccine Prevents Cancer
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.
